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ABSTRACT
Psoriasis represents the major common dermatosis of multifactorial determination. The fundamental evolutionary biology of environs bearing skin 
and revelations on multistep involvement of oxidative stress in pathogenic events of psoriasis makes a strong case for medical contemplation. Very 
clearly the perspectives of dietetics in avoidance and amelioration of psoriasis, emerge as the least addressed in contemporary care, even at specialty 
level. An attempt is made to discuss the multistep pathogenic indulgence of oxidative stress to emphasize the worth attention to dietetic intervention 
toward rational and desired management of psoriasis.
Keywords: Psoriasis, Oxidative stress, Antioxidants, Apoptosis, Keratinocyte.
INTRODUCTION
Skin is guardian of homeostasis in the face of varied environmental 
conditions. The constant renewal of keratinocytes provides protection as 
a barrier. External insults provoke protective mechanisms, particularly, 
inflammation. Removal of old cells occurs through biological process 
of apoptosis. There is a balance between keratinocyte renewal 
and apoptosis. The horny skin layer made of dead keratinocytes is 
protective against physical and chemical insults and desquamation 
sheds microbial contaminants.
THE PROCESS OF APOPTOSIS
Apoptosis is self-regulated cellular suicide controlled at the organ 
level [1,2]. This process proceeds in several stages. These include 
reception of apoptotic stimuli, transduction of signal to cell nucleus, 
activation of lethal or killer genes, and consequent transcription of 
specific apoptotic proteins. Finally, the endonucleases are activated 
causing breakdown of DNA. A number of internal as well as external 
factors control apoptosis. These include hormones, cytokines, 
antioxidants, reactive oxygen species (ROS), calcium ion fluxes (Ca2+), 
and different physical and chemical agents [3]. The influence of all these 
finds way through different signal transduction paths. Complex effects 
occur on phospholipase, sphingomyelin, tyrosine kinase, and protein 
kinase pathways that are regulating proliferation and differentiation of 
keratinocytes.
Oxidative stress is important in modulation of apoptosis [4-8]. 
Apoptosis is predominantly a gene regulated process with specific 
provoking [9-11] and blocking [12-14] determinants.
Higher expression of both the apoptotic signal receptors Fas and the 
anti-apoptotic proteins Bcl-x in skin is demonstrated in psoriasis [8]. 
This indicates the disturbance in differentiation and programming in 
apoptosis [15]. In addition, other apoptotic proteins and proliferation 
molecules are increased in expression in the disease [16]. Psoriasis 
accompanies activation of apoptotic genes Fas and p53 and anti-
apoptotic protective Bcl2, Bclx and Ki67 systems. Metabolic state of 
keratinocytes is a more responsive to apoptotic signals, through finite 
mechanism are not yet defined. The process of apoptosis is nevertheless, 
closely linked to the redox balance in the tissue [7].
KERATINOCYTE HYPERPROLIFERATION
ROS have high reactivity and short life span. They involved in local 
regulation of proliferation [6,12] vascular tone [17] and induction 
of specific genes [18]. ROS also participate as second messengers 
in activating apoptotic genes [5]. Several genes encoding cytokines 
are activated [4]. Synthesis of cyclic guanosine monophosphate, an 
important component of intra and extracellular communications is 
modulated by nitric oxide and carbon monoxide, functioning in tandem 
with the ROS [17-20].
Enhanced formation of ROS and lipid peroxidation (LPO) is implicated 
in pathogenesis of variety of diseases, but psoriasis uniquely 
exhibits low level of LPO. Such state of cell membranes favors 
ready proliferation. Enhanced synthesis of antioxidant and anti-
apoptotic Bcl-x proteins [8,21] may support pathologic shift toward 
hyperproliferation of keratinocytes, seen in the disease. Conditions 
triggering differentiation and apoptosis in superficial keratinocytes 
hold key to pathogenesis of psoriasis and variety of stimuli have a 
determinant role [3]. Equally the keratinocyte readiness to perceive 
signals and the antioxidant extracellular milieu [7,21] are important.
Skin evolved in environment of oxygen which naturally impact [5] 
processes of development, maturation and death of keratinocytes, by 
continuous exposure to free environment. In psoriasis, keratinocytes 
grow rapidly within inflammatory environment and low LPO profile. 
This cuts short the proper differentiation or maturation events. Rapidly 
the cells face oxidative stress with an expression of apoptotic receptors 
Fas [15] and p53 [16]. Oxidative stress induced apoptosis of the 
granular layer cells results in the formation of defective horny layer, the 
key feature driving skin damage spread and chronicity of the disease.
Learning points
•  Increased proliferation and apoptosis of keratinocytes is well 
known in psoriasis.
•  It is increased sensitivity, mediated by metabolic effects and induced 
antioxidant enzymes that propells apoptosis in psoriasis. ROS are 
the obvious causal factors for such changes in psoriasis. They 
involve directly and also through various other secondary effective 
molecular processes crucial in hyper proliferation and apoptosis.
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IMMUNE DYSFUNCTION
Current findings in psoriasis indicate to autoimmune pathogenesis. 
Elevated circulating immune complexes correlate duration and severity 
of the disease. Injuries by scratches provoke inflammation. Intense 
proliferation associating inflammation with activated proteolysis 
uncovers latent skin antigens liable to activating synthesis of 
autoantibodies. Normally, the lymphocyte clones engaging in synthesis 
of autoantibodies are eliminated by regulatory immune mechanism. 
The low LPO in psoriatic keratinocytes and ROS involved apoptosis 
impairs immunological regulatory mechanisms [22]. The vicious circle 
perpetuates to spread psoriasis lesions.
Inflammation and leukocyte activation are initiated with the release of 
inflammatory mediators following deposition of immune complexes 
and binding of complement components in cutaneous microvasculature. 
Intense inflammation results in local hypoxia and lower antioxidant 
profile further stimulating of keratinocyte proliferation.
Psoriasis represents a genotypic multifactorial dermatosis. Genes 
encoding apoptotic receptor Fas and anti-apoptotic Bcl2 and Bclx 
proteins, as well as enzymatic and nonenzymatic antioxidant 
mechanisms are prominently at focus of psoriasis molecular 
biology [15,23,24]. Clonal selection of autoantibody-producing cells is 
affected by changes in LPO and disturbances in apoptosis. On the other 
hand, activation of antioxidant mechanisms in reaction to infection 
only aggravates psoriasis. The infectious and immunological concept of 
psoriasis is based on such revelations.
Learning points
•  Autoimmune mechanisms are believed to be involved in 
pathogenesis of psoriasis. The current therapies attempt to control 
their effects and effectors but not the causal factors.
•  ROS are linked to autoimmunity by exposing latent skin antigens 
as well as causing impairment of immune regulatory mechanisms. 
They have major causal relation to autoimmunity in psoriasis.
NEURO-ENDOCRINE DISORDER
The development of psoriasis with emotional and autonomic 
disturbances calls attention to role of Neuroendocrine mechanisms 
in pathogenesis. The pituitary-adrenal system has intricate role in the 
regulation of stress responses and inflammation [25]. The process 
of apoptosis is subject to hormonal influences and its disorder 
is crucial in the pathogenesis of psoriasis. This is confounded by 
psychophysiological disruptions consequent to stigma [26,27] and 
an impact of adverse personal habits [28]. Subtle impacts of the 
neuroendocrine disturbances may compromise microcirculation in 
skin hypoxia triggers paracrine mechanisms aggravating pathology 
with major involvement of ROS [29,30].
Learning points
•  Stress is well known to associate with and aggravate psoriasis.
•  The neuro-endocrine activity of stress affects microcirculation 
and is trigger to pathogenic mechanisms involving major role of 
oxidative stress.
INTERPLAY OF ROS, ANTIOXIDANTS AND CYTOKINES
Redox state (i.e., the balance between pro and anti-oxidant activities) 
of cells is regulator of fundamental process as signal transduction, 
gene expression, inflammation, and apoptosis [31,32]. Among the bio-
molecules generated by influence of oxidative stress, cytokines are 
the major regulators of immune responses and are involved in driving 
inflammation, carcinogenesis, and apoptosis [33,34]. Antioxidant 
defense includes enzymes and low molecular compounds. Enzymes are 
superoxide dismutase, catalase, glutathione peroxidase, and glutathione 
reductase. Low molecular antioxidants are glutathione, contributing 
to recycling of other oxidized antioxidants, uric acid, ascorbic acid, 
and lipid soluble α-tocopherol. Keratinocytes produce some cytokines 
physiologically but can be induced to produce and release pro-
inflammatory cytokines that involve ROS as mediators [35]. Among 
the multiple cytokines produced, interleukin 1β and tumor necrosis 
factor-α (TNF-α) are known to induce cellular production of ROS. The 
relationship between the redox state and cytokines has a key role in 
cutaneous pathophysiology via cellular pathways. These pathways 
contain phosphorylation and gene expression which are mediated 
mainly by NFκB, nitric oxide radicals and proteins kinases [36].
The redox state and cytokines play a major role in redox cutaneous 
homeostasis and interference in ROS-induced immune modulation can 
associate immune disorder of skin [37]. Since antioxidant imbalance 
is implicated in the pathogenesis of inflammatory skin disease, 
supplementation of antioxidants appeals as a rational approach to 
restore homeostasis. Pro-inflammatory cytokines interleukin-8, TNF-α, 
and interferon-γ produced in excess from psoriatic keratinocytes also 
promote inducible nitric oxide synthase expression in the cell [38]. 
Under influence of the stated cytokines, the enzyme produces nitric 
oxide radicals which play a key role in recruiting T-lymphocytes and 
neutrophils. The immune-mediated inflammation is thus established 
and perpetuated.
Learning points
•  Dominant role of cytokines in pathology of psoriasis is established.
•  It is the relationship between the cytokines and the oxidative stress 
that plays a pivotal role in pathophysiology of psoriasis via diverse 
cellular pathways of immune and inflammatory mechanisms.
PROSPECTS FOR PROTECTIVE/AMELIORATIVE DIETETICS
The dietetic perspectives based on contemporary understanding were 
earlier reviewed [36]. Psoriasis has distinct pathogenesis yet bears 
strong association with co-morbidity of metabolic syndrome [39]. 
This has to be based on the causative elements of metabolic syndrome 
and psoriasis sharing inflammation as feature [40]. There are reports 
of benefit of fasting and calories restriction in psoriasis also [41]. The 
specific dietetic perspective need to adapt to the same concerns that 
envisage advances in future psoriasis therapy [42]. There is need to 
develop phenotypic understanding toward refining preventive and 
ameliorative strategies in drugs and dietetic management. Focus is to 
be on bioregulatory agents that only check aberrant and not normal 
immune/inflammatory and proliferative function. These should target 
signaling pathways, regulate balance of lymphocyte subset functions, 
specifically counter aggressive cytokines, and mediators of various 
facets in disease pathogenesis.
The inflammatory triggers release arachidonic acid from membrane 
phospholipids to generate 2-carbon series of potent inflammatory 
eicosanoid mediators. Meat products are rich in arachidonic 
acid. Mixed vegetable oils and sunflower oil contribute to linoleic 
acid consumption which gets converted to arachidonic acid. 
Monounsaturated fat, e.g., olive oil consumption avoids this. The 
omega-3 fats and gamma linolenic acid produce 1 and 3 carbon 
anti-inflammatory eicosanoids. Omega-3 fat Eicosapentaenoic acid 
is available in fish oil and cold water fish. Flax seed provides alfa-
linolenic acid that gets converted to the eicosapentaenoic acid. Borage 
seed oil, black current oil, evening primrose oil all promote 1-C series 
eicosanoid synthesis [43-46].
Antioxidant micronutrients as vitamin C, vitamin E, selenium, beta-
carotene, etc., as well as vitamin B, especially B6 and magnesium, 
selenium, serve as cofactors and coenzymes to enhance synthesis 
of the anti-inflammatory 1-C and 3-C series eicosanoids. These also 
to an extent disrupt inflammatory processes provoked by cytokine 
TNF-α [47].
Bioactive compounds in many herbs are directly inhibitory to enzymes 
cyclo-oxygenase and lipoxygenases which make inflammatory 2-C 
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series eicosanoids from arachidonic acid. Such usefulness is seen 
with curcumin, ginger, boswellia, white willow, etc., all of which are 
edible [48-50].
Inflammatory cytokines, e.g., TNF-α activate transcription factor 
NFκB which then upregulates genes coding inflammatory proteins 
and hyperproliferative mediators as interleukins-1, 6, 8, etc. 
Natural agents as curcumin, quercetin, vitamin B6 and catechins 
can downregulate TNF-α and NFκB in over activated inflammatory 
cells as macrophages, without affecting blissfully, the normal level 
inflammatory capability. The effect is uniquely bioregulatory. Again 
the stated bioactive agents are easily available from edible plant 
resource. Reishi mushrooms and astragalus are very effective 
too [51].
Vitamin D has unique role to benefit immune-mediated inflammatory 
state by promoting formation of anti-inflammatory cytokines 
interleukin 4 and anti-microbial peptides, again exhibiting bio-
regulatory effect [52]. Folate is found to be particularly scavenger of 
peroxynitrile radicals, so important in psoriatic inflammation [53].
Prebiotics and probiotics exert a significant immunomodulatory 
effect as well [54,55]. The reports emphasize crucial need to improve 
micronutrients in diet. This may summarily be helped by increasing 
consumption of fruits, nuts, seeds, non-starchy vegetables, and fish. 
Cruciferous vegetables are particularly protective. On the contrary 
above information suggests need to avoid excess dairy products, meat 
consumption, sugary refined foods and drinks. Very prudent is to give 
up alcohol and smoking.
Learning points
•  Dietary items are known to have pro- and anti-inflammatory 
potentials and in psoriasis anti-inflammatory foods are preferable 
while pro-inflammatory food is avoidable.
•  There are evolutionary and biochemical/immunological bases of 
choosing from available dietary options. The role of dietary factors 
in epigenome function is crucial to appreciate and consider in 
individual cases.
•  The micronutrient balanced or enriched nutrition is suggestive of 
critical significance in management and prevention of psoriasis.
•  Convergence with dietetic selection and application is integral to 
rational psoriasis management.
EPILOGUE
Traditionally, the topical agents as corticosteroids, retinoids, and 
vitamin D3 analogs, systemic methotrexate, ciclosporin, and retinoids 
as well as phototherapy form therapeutic means. Their inconvenience 
and adverse effects compromise the adherence to and success of 
therapy, particularly in early mild disease. The immunologicals 
developed through biotechnology advances are visibly too slow to find 
favor in dermatology practice at large. There is interest in immune-
modulatory – anti-inflammatory less toxic and acceptable oral agents 
such as fumarate [56], cannabinoids, allopurinol, and loratadine [57] 
and new class of the phosphodiesterase-4 inhibitors [58]. The overview 
of events in psoriasis pathogenesis reveals the significance of resting 
derailed index of cutaneous redox state for therapeutic rationale. Such 
a shift would reduce inflammation and improve microcirculation and 
proper tissue respiration, reducing risk of vascular endothelial growth 
factor production, which appears to be important in persistence and 
spread of psoriatic skin lesion [59]. Modern emphasis of evolving 
systems approach is on attempting personalized therapeutics [60]. 
The technical aids for the same are only developing. High and low 
responders to oxidative stress may involve genetic determinants 
but also nutrition shall answer such challenge. The advances in 
understanding on protective nutrients and harmful nutrients are 
impressive and represent very logical intervention to comprehensive 
rational management of psoriasis.
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